TFS Capital’s Intermolecular, Inc. IMI Stock Holding History

TFS Capital’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-33,621	Closed	-$78K	–	1310
2014 Q2	$78K	Buy	+33,621	New	+$84K	0.01%	1067
2014 Q1	–	Sell	-21,428	Closed	-$105K	–	1695
2013 Q4	$105K	Sell	21,428 -51,958	-71%	-$293K	0.01%	1394
2013 Q3	$404K	Sell	73,386 -39,436	-35%	-$248K	0.02%	977
2013 Q2	$820K	Buy	+112,822	New	+$960K	0.03%	697

Other funds holding IMI

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPM

Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

TFS Capital's IMI Position: Q3 2014 in Review

TFS Capital sold out of Intermolecular, Inc. (IMI) in Q3 2014, closing a stake of 33,621 shares — an estimated $78K sold.

TFS Capital first reported a position in IMI in Q2 2013 and held it in 4 quarters. The position peaked at $820K in Q2 2013. 33 funds tracked by Wall St. Rank hold IMI as of Q3 2014.

TFS Capital reported no remaining Intermolecular, Inc. position as of Q3 2014 after selling out during the quarter.
TFS Capital sold 33,621 Intermolecular, Inc. shares in Q3 2014, an estimated $78K.
TFS Capital first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 4 quarters.
TFS Capital's Intermolecular, Inc. position peaked at $820K in Q2 2013.
33 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2014.

Based on TFS Capital's 13F filing for Q3 2014, filed 6 Nov 2014.